CAS 948570-30-7

Rontalizumab

CAS : 948570-30-7

Rontalizumab

Degré de pureté : ≥95%

Ref: 54-BUP20301

Rontalizumab

CAS : 948570-30-7

Rontalizumab (RhuMab IFNalpha) is a humanized monoclonal antibody that neutralizes IFNalpha, used in the research of systemic lupus erythematosus.

Degré de pureté : 96.87% (SEC-HPLC) - 97.73% (SEC-HPLC)

Couleur et forme : Liquid

Masse moléculaire : 146.18 kDa

Ref: TM-T81259

Rontalizumab

CAS : 948570-30-7

Anti-IFN-α Humanized monoclonal antibody; potential treatment of systemic lupus erythematosus

Ref: 3D-CLA1244